Cardiovascular outcomes associated with SGLT-2 inhibitors versus other glucose-lowering drugs in patients with type 2 diabetes: a real-world systematic review and meta-analysis
[DOI] [PubMed] [Google Scholar] 84.Newsome P.N., Buchholtz K., Cusi K., Linder M., Okanoue T., Ratziu V., Sanyal A.J., Sejling A.S., Harrison S.A., NN9931-4296 Investigators A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
Acetaminophen concentrations obtained earlier than 4 hours post-ingestion may be misleading as they may not represent maximum acetaminophen concentrations
Megaloblastic anemias: nutritional and other causes
Amoxicillin was selected as the comparator because it's prescribed for the same type of conditions as azithromycin but is not linked to increased risk of cardiovascular events
The study is the largest sample of patients with overweight or obesity treated with semaglutide for more than a year via telehealth